Advertisement

A research agenda for selective screening for asymptomatic carotid artery stenosis

Published:November 02, 2022DOI:https://doi.org/10.1016/j.ijcard.2022.10.168
      With cardiovascular disease (CVD) remaining one of the most common causes of premature death and disability worldwide, screening for precursors of CVD to delay or prevent adverse health outcomes by early detection and intervention has the potential to improve public health. In this context, screening for asymptomatic carotid artery stenosis (ACAS) receives increasing attention.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Paraskevas K.I.
        • Spence J.D.
        • Mikhailidis D.P.
        • Antignani P.L.
        • Gloviczki P.
        • Eckstein H.H.
        • et al.
        Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial.
        Int. J. Cardiol. 2022;
        • Naylor R.
        • Rantner B.
        • Ancetti S.
        • de Borst G.J.
        • De Carlo M.
        • Halliday A.
        • et al.
        European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease.
        Eur. J. Vasc. Endovasc. Surg. 2022;
        • AbuRahma A.F.
        • Avgerinos E.D.
        • Chang R.W.
        • Darling 3rd, R.C.
        • Duncan A.A.
        • Forbes T.L.
        • et al.
        Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease.
        J. Vasc. Surg. 2022; 75: 4s-22s
        • Krist A.H.
        • Davidson K.W.
        • Mangione C.M.
        • Barry M.J.
        • Cabana M.
        • Caughey A.B.
        • et al.
        Screening for asymptomatic carotid artery stenosis: US preventive services task force recommendation statement.
        JAMA. 2021; 325: 476-481
        • Högberg D.
        • Björck M.
        • Mani K.
        • Svensjö S.
        • Wanhainen A.
        Five year outcomes in men screened for carotid artery stenosis at 65 years of age: a population based cohort study.
        Eur. J. Vasc. Endovasc. Surg. 2019; 57: 759-766
        • Poorthuis M.H.F.
        • Halliday A.
        • Massa M.S.
        • Sherliker P.
        • Clack R.
        • Morris D.R.
        • et al.
        Validation of risk prediction models to detect asymptomatic carotid stenosis.
        J. Am. Heart Assoc. 2020; 9e014766
        • Poorthuis M.H.F.
        • Sherliker P.
        • Morris D.R.
        • Massa M.S.
        • Clarke R.
        • Staplin N.
        • et al.
        Development and internal validation of a risk Score to detect asymptomatic carotid stenosis.
        Eur. J. Vasc. Endovasc. Surg. 2021; 61: 365-373
        • Spence J.D.
        • Coates V.
        • Li H.
        • Tamayo A.
        • Muñoz C.
        • Hackam D.G.
        • et al.
        Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis.
        Arch. Neurol. 2010; 67: 180-186
        • Poorthuis M.H.F.
        • Herings R.A.R.
        • Dansey K.
        • Damen J.A.A.
        • Greving J.P.
        • Schermerhorn M.L.
        • et al.
        External validation of risk prediction models to improve selection of patients for carotid endarterectomy.
        Stroke. 2022; 53: 87-99
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • Lane D.A.
        • Crijns H.J.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
        Chest. 2010; 137: 263-272

      Linked Article